REGN
Regeneron Pharmaceuticals Inc
735.20$
+0.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.5% | +7.5% | +11.5% | +2.1% | +5.4% | -4.5% | +6.4% | +3.4% | +15.9% | -28.8% | +14.9% | +10.5% | +6.9% | -1.9% | +6.8% | +17.5% | +5.6% | +4.4% | +103.2% | -32.8% | +43.4% | -40.1% | -3.6% | +2.8% | +16.3% | -7.4% | -0.1% | +6.5% | +2.1% | -8.4% | +12.8% | +4.9% | +1.8% | -20.1% | +21.4% | +2.1% | +3.5% | -7.2% | +19.0% | – | |
| – | +43.7% | +18.1% | +12.9% | +2.8% | -1.2% | +7.8% | -17.2% | +16.4% | +9.7% | +39.5% | -11.3% | +40.7% | -0.9% | -0.9% | +22.3% | -0.3% | +24.5% | -9.5% | +103.7% | -31.2% | +100.8% | -54.7% | -22.5% | +10.5% | +23.5% | +9.9% | -8.8% | +6.7% | +16.1% | -31.0% | +10.7% | +2.3% | +15.1% | -17.9% | +14.2% | -1.6% | +12.1% | +14.5% | -13.9% | – | |
| – | -2.2% | +6.5% | +11.3% | +2.0% | +6.1% | -5.7% | +9.0% | +2.4% | +16.5% | -35.0% | +20.0% | +6.2% | +8.3% | -2.1% | +4.0% | +21.2% | +2.4% | +7.2% | +103.1% | -33.1% | +33.1% | -36.2% | 0.0% | +1.6% | +15.1% | -10.4% | +1.7% | +6.4% | -0.6% | -3.4% | +13.1% | +5.3% | -0.2% | -20.5% | +22.7% | +2.8% | +2.1% | -11.0% | +26.5% | – | |
| – | -12.6% | +4.2% | +1.2% | +3.6% | +0.3% | -6.3% | +7.2% | +5.2% | +7.1% | -22.1% | +91.5% | -43.2% | +44.4% | -22.7% | +25.7% | -5.7% | +9.2% | -1.1% | -4.8% | -7.9% | +20.1% | +8.2% | -6.4% | +13.7% | +15.0% | +6.4% | -1.9% | -1.3% | +8.3% | +19.5% | -2.5% | +8.5% | +7.4% | -6.0% | +6.9% | +8.8% | +4.4% | +1.2% | -0.8% | – | |
| – | +20.7% | -8.9% | +3.4% | 0.0% | +33.6% | -19.3% | +10.3% | +1.2% | +33.1% | -16.4% | +1.6% | +0.6% | +39.7% | -37.4% | -5.2% | -6.1% | +12.4% | +10.4% | +2.2% | +7.3% | +25.8% | -19.6% | +5.8% | +11.1% | +24.8% | -9.0% | +8.5% | -1.8% | +15.2% | -6.6% | +10.1% | -5.9% | +10.9% | -20.1% | +0.2% | +3.7% | +17.8% | -16.4% | +2.2% | – | |
| – | -1.1% | -1.3% | +2.0% | +2.2% | +13.1% | -12.2% | +8.5% | +3.5% | +17.8% | -36.2% | +59.0% | -31.7% | +25.5% | -6.3% | +12.5% | -5.6% | -7.3% | +23.7% | -1.4% | +5.1% | +16.3% | -4.4% | -1.7% | +10.5% | +22.3% | +0.6% | +2.0% | -1.5% | +9.0% | +11.7% | +1.9% | +2.6% | +9.0% | -11.7% | +4.7% | +6.8% | +9.7% | -5.2% | +0.0% | – | |
| – | -4.4% | +24.1% | +27.8% | +1.7% | -3.8% | +5.3% | +9.7% | +0.8% | +14.5% | -33.2% | -34.3% | +134.0% | -8.5% | +3.6% | -6.2% | +60.4% | +10.8% | -4.7% | +200.8% | -44.8% | +42.9% | -51.3% | +1.6% | -6.4% | +7.5% | -23.8% | +1.4% | +19.1% | -13.2% | -28.5% | +42.3% | +10.3% | -16.0% | -40.2% | +82.4% | -4.9% | -14.3% | -26.9% | +121.0% | – | |
| – | +584.3% | +121.0% | -28.0% | +14.5% | -2.4% | +6.7% | +7.4% | +8.3% | -1.9% | +4.8% | +3.9% | -2.5% | -14.1% | -9.0% | +59.0% | +171.1% | -43.7% | -1.4% | -1.4% | -1.4% | -0.7% | -3.5% | -3.7% | +16.8% | +13.7% | +3.4% | +5.0% | -5.8% | +2.8% | -12.0% | -8.1% | -6.8% | -23.9% | -17.1% | -58.6% | +436.1% | -36.8% | +5.7% | -14.7% | – | |
| – | -6.7% | +26.6% | +21.6% | +7.6% | -1.9% | +5.5% | +12.1% | -3.1% | +6.3% | -19.2% | -58.9% | +242.0% | +15.8% | -24.9% | +37.4% | +8.6% | +22.7% | +2.3% | +199.5% | -51.6% | +37.8% | -57.6% | -9.2% | +56.7% | -12.3% | -35.2% | +26.2% | +2.6% | +3.3% | -38.9% | +132.4% | -8.3% | -35.8% | -5.5% | +67.8% | +16.1% | -40.8% | -20.4% | +83.8% | – | |
| – | -12.5% | +107.4% | -24.7% | +28.4% | +115.0% | -71.8% | -2.6% | -60.6% | -449.9% | – | -62.8% | +213.0% | -1.1% | -55.0% | -50.9% | +623.1% | -51.7% | +82.8% | +374.5% | -71.8% | +48.8% | -68.1% | +26.8% | +74.7% | -34.3% | -68.5% | +184.8% | -10.0% | -111.7% | – | – | -22.2% | -73.5% | +138.4% | +32.0% | +138.6% | -34.4% | -47.8% | +122.0% | – | |
| – | -4.4% | -1.7% | +55.8% | +0.1% | -55.3% | +175.5% | +15.4% | +7.8% | +38.0% | -43.8% | -58.1% | +246.8% | +18.3% | -21.1% | +43.7% | -6.2% | +36.5% | -3.0% | +177.9% | -47.3% | +36.6% | -56.3% | -12.5% | +54.4% | -9.0% | -31.7% | +18.4% | +4.1% | +15.1% | -37.7% | +98.4% | -6.4% | -31.5% | -11.9% | +72.1% | +4.9% | -42.2% | -13.9% | +78.3% | – | |
| – | -6.0% | +29.0% | +18.5% | +7.6% | -2.3% | +5.5% | +10.9% | -2.6% | +7.0% | -16.7% | -52.9% | +191.2% | +14.7% | -23.1% | +35.1% | +9.8% | +20.0% | +2.6% | +187.5% | -50.4% | +36.1% | -55.7% | -8.6% | +54.0% | -10.8% | -32.4% | +23.5% | +2.4% | +3.6% | -35.0% | +112.3% | -7.7% | -32.8% | -5.0% | +59.3% | +15.8% | -37.4% | -19.5% | +71.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.